Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Sanara MedTech (SMTI) over the last 14 years, with Q3 2025 value amounting to -$3.4 million.

  • Sanara MedTech's Cash from Investing Activities rose 4618.92% to -$3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.7 million, marking a year-over-year decrease of 9367.74%. This contributed to the annual value of -$6.6 million for FY2024, which is 3522.66% up from last year.
  • Sanara MedTech's Cash from Investing Activities amounted to -$3.4 million in Q3 2025, which was up 4618.92% from -$3.9 million recorded in Q2 2025.
  • Sanara MedTech's 5-year Cash from Investing Activities high stood at -$12945.0 for Q2 2023, and its period low was -$10.1 million during Q3 2023.
  • Its 5-year average for Cash from Investing Activities is -$2.0 million, with a median of -$604391.0 in 2021.
  • As far as peak fluctuations go, Sanara MedTech's Cash from Investing Activities surged by 9938.06% in 2023, and later crashed by 776996.72% in 2025.
  • Over the past 5 years, Sanara MedTech's Cash from Investing Activities (Quarter) stood at -$1.5 million in 2021, then surged by 74.73% to -$376954.0 in 2022, then skyrocketed by 85.6% to -$54276.0 in 2023, then plummeted by 139.51% to -$129994.0 in 2024, then plummeted by 2531.5% to -$3.4 million in 2025.
  • Its Cash from Investing Activities was -$3.4 million in Q3 2025, compared to -$3.9 million in Q2 2025 and -$5.2 million in Q1 2025.